| Field | Specification |
|---|---|
| Mfr No | |
| Activity | |
| Alternative Names | 6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic acid 2-(4-morpholinyl)ethyl ester |
| Cas No. | |
| Form | White powder |
| Molecular Weight | |
| Product Type | |
| Purity | |
| Shipping | |
| SMILES | |
| Solubility | May be dissolved in DMSO (40 mg/ml); or ethanol (4 mg/ml) |
| Source | Synthetic |
| Storage |
Mycophenolate mofetil is an immunosuppressive agent that is metabolized in vivo to mycophenolic acid, which inhibits inosine monophosphate dehydrogenase. This inhibition disrupts guanine nucleotide synthesis, leading to suppression of T cell proliferation and cytokine production. In neuroscience, Mycophenolate mofetil has been shown to reduce microglial and astrocytic activation, thereby mitigating neuroinflammation and neuronal injury. Its ability to modulate immune responses makes it a valuable tool in studying neuroimmune interactions and potential therapeutic strategies for neurodegenerative diseases.
GHS Classifcation:
GHS07 Acute toxicity (oral, dermal, inhalation), category 4, Skin irritation, category 2, Eye irritation, category 2, Skin sensitisation, category 1, Specific Target Organ Toxicity – Single exposure, category 3 AND GHSO9 Hazardous to the aquatic environment, Acute hazard, category1, Chronic hazard, categories 1,2 Hazard statement(s): H302-H400 Precautionary statement(s): P273
Mycophenolate mofetil (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-568)
Need this compound in a format that drops straight into your assay? We can tailor formulation, chemistry, and documentation so your results stay consistent across runs and re-orders.
- Format options: solid or pre-dissolved solution (choose solvent), target concentration, aliquots, light/moisture-protected packaging
- Chemistry options: free base/acid vs salt forms, hydrate/solvate preference, stereoisomer control (single enantiomer or racemate), close analogs
- Add-on labels & handles: D/¹³C/¹⁵N isotopes (LC-MS/internal standards), azide/alkyne or other functional handles for conjugation
- QC & documentation: standard COA or enhanced analytical pack (HPLC/LC-MS/NMR), chiral purity, residual solvents, water content (KF), method-specific specs
- Scale & continuity: mg to gram scale, bulk pricing, lot reservation, repeat-order continuity
To quote quickly, tell us: compound name + CAS/structure (SMILES or mol file), intended assay context, solvent preference, salt/stereochemistry requirements, purity/QC level, and the amount (mg–g).
Can’t find the compound you’re looking for?
Send the CAS or structure and your specs. We can help source it, suggest close
equivalents, or discuss custom synthesis with the right QC documentation (RUO).
2. Jonsson C.A., et al., (2002) Cell. Immunol. 216:93.
3. Allison A.C., et al., (1993) Ann. NY Acad. Sci. 696:63.
4. Quemeneur J., et al., (2002) J. Immunol. 169:2747
5. Ebrahimi F., et al., (2012) J. Neuroinflammation 9:89.
